Literature DB >> 20381638

Host responses to Candida albicans: Th17 cells and mucosal candidiasis.

Heather R Conti1, Sarah L Gaffen.   

Abstract

Candida albicans causes mucosal and disseminated candidiasis, which represent serious problems for the rapidly expanding immunocompromised population. Until recently, Th1-mediated immunity was thought to confer the primary protection, particularly for oral candidiasis. However, emerging data indicate that the newly-defined Th17 compartment appears to play the predominant role in mucosal candidiasis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20381638      PMCID: PMC2892252          DOI: 10.1016/j.micinf.2010.03.013

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  86 in total

1.  A genome-wide association study identifies IL23R as an inflammatory bowel disease gene.

Authors:  Richard H Duerr; Kent D Taylor; Steven R Brant; John D Rioux; Mark S Silverberg; Mark J Daly; A Hillary Steinhart; Clara Abraham; Miguel Regueiro; Anne Griffiths; Themistocles Dassopoulos; Alain Bitton; Huiying Yang; Stephan Targan; Lisa Wu Datta; Emily O Kistner; L Philip Schumm; Annette T Lee; Peter K Gregersen; M Michael Barmada; Jerome I Rotter; Dan L Nicolae; Judy H Cho
Journal:  Science       Date:  2006-10-26       Impact factor: 47.728

Review 2.  Anticandidal immunity and vaginitis: novel opportunities for immune intervention.

Authors:  Antonio Cassone; Flavia De Bernardis; Giorgio Santoni
Journal:  Infect Immun       Date:  2007-06-11       Impact factor: 3.441

Review 3.  An outline of the role of anti-Candida antibodies within the context of passive immunization and protection from candidiasis.

Authors:  A Cassone; F De Bernardis; A Torososantucci
Journal:  Curr Mol Med       Date:  2005-06       Impact factor: 2.222

Review 4.  Candida-host interactions in HIV disease: relationships in oropharyngeal candidiasis.

Authors:  P L Fidel
Journal:  Adv Dent Res       Date:  2006-04-01

Review 5.  NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production?

Authors:  Jurg Tschopp; Kate Schroder
Journal:  Nat Rev Immunol       Date:  2010-02-19       Impact factor: 53.106

6.  Regulation of IL-9 expression by IL-25 signaling.

Authors:  Pornpimon Angkasekwinai; Seon Hee Chang; Manoj Thapa; Hiroshi Watarai; Chen Dong
Journal:  Nat Immunol       Date:  2010-02-14       Impact factor: 25.606

7.  Identification of functional roles for both IL-17RB and IL-17RA in mediating IL-25-induced activities.

Authors:  Erika A Rickel; Lori A Siegel; Bo-Rin Park Yoon; James B Rottman; David G Kugler; David A Swart; Penny M Anders; Joel E Tocker; Michael R Comeau; Alison L Budelsky
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

Review 8.  Animal models of mucosal Candida infection.

Authors:  Julian R Naglik; Paul L Fidel; Frank C Odds
Journal:  FEMS Microbiol Lett       Date:  2008-04-16       Impact factor: 2.742

Review 9.  Cytokine-mediated regulation of antimicrobial proteins.

Authors:  Jay K Kolls; Paul B McCray; Yvonne R Chan
Journal:  Nat Rev Immunol       Date:  2008-11       Impact factor: 53.106

Review 10.  The role of interleukin-17 in the pathogenesis of rheumatoid arthritis.

Authors:  Sarah L Gaffen
Journal:  Curr Rheumatol Rep       Date:  2009-10       Impact factor: 4.592

View more
  52 in total

1.  [Not Available].

Authors:  Jf Arnould; R Le Floch
Journal:  Ann Burns Fire Disasters       Date:  2015-03-31

2.  A Candida albicans Strain Expressing Mammalian Interleukin-17A Results in Early Control of Fungal Growth during Disseminated Infection.

Authors:  Anna R Huppler; Natasha Whibley; Carol A Woolford; Erin E Childs; Jie He; Partha S Biswas; Mandy J McGeachy; Aaron P Mitchell; Sarah L Gaffen
Journal:  Infect Immun       Date:  2015-07-06       Impact factor: 3.441

3.  Novel Role for Interleukin-17 in Enhancing Type 1 Helper T Cell Immunity in the Female Genital Tract following Mucosal Herpes Simplex Virus 2 Vaccination.

Authors:  Puja Bagri; Varun C Anipindi; Philip V Nguyen; Danielle Vitali; Martin R Stämpfli; Charu Kaushic
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

Review 4.  Inborn errors of mucocutaneous immunity to Candida albicans in humans: a role for IL-17 cytokines?

Authors:  Anne Puel; Capucine Picard; Sophie Cypowyj; Desa Lilic; Laurent Abel; Jean-Laurent Casanova
Journal:  Curr Opin Immunol       Date:  2010-07-30       Impact factor: 7.486

Review 5.  IL-17-Mediated Immunity to the Opportunistic Fungal Pathogen Candida albicans.

Authors:  Heather R Conti; Sarah L Gaffen
Journal:  J Immunol       Date:  2015-08-01       Impact factor: 5.422

Review 6.  Interaction of Candida albicans with host cells: virulence factors, host defense, escape strategies, and the microbiota.

Authors:  Sarah Höfs; Selene Mogavero; Bernhard Hube
Journal:  J Microbiol       Date:  2016-02-27       Impact factor: 3.422

7.  Oral lactoferrin protects against experimental candidiasis in mice.

Authors:  K Velliyagounder; W Alsaedi; W Alabdulmohsen; K Markowitz; D H Fine
Journal:  J Appl Microbiol       Date:  2014-11-25       Impact factor: 3.772

8.  Candida albicans morphology and dendritic cell subsets determine T helper cell differentiation.

Authors:  Sakeen W Kashem; Botond Z Igyarto; Maryam Gerami-Nejad; Yosuke Kumamoto; Javed A Mohammed; Elizabeth Jarrett; Rebecca A Drummond; Sandra M Zurawski; Gerard Zurawski; Judith Berman; Akiko Iwasaki; Gordon D Brown; Daniel H Kaplan
Journal:  Immunity       Date:  2015-02-10       Impact factor: 31.745

9.  The Cek1‑mediated MAP kinase pathway regulates exposure of α‑1,2 and β‑1,2‑mannosides in the cell wall of Candida albicans modulating immune recognition.

Authors:  E Román; I Correia; A Salazin; C Fradin; T Jouault; D Poulain; F-T Liu; J Pla
Journal:  Virulence       Date:  2016-05-18       Impact factor: 5.882

Review 10.  Molecular mechanisms of mucocutaneous immunity against Candida and Staphylococcus species.

Authors:  László Maródi; Sophie Cypowyj; Beáta Tóth; Liudmyla Chernyshova; Anne Puel; Jean-Laurent Casanova
Journal:  J Allergy Clin Immunol       Date:  2012-10-03       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.